MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/irv.12771

Медицинская библиотека · Influenza and other respiratory viruses · 2020

Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17.

Jackson Sandra, Peret Teresa C T, Ziegler Thedi T, Thornburg Natalie J, Besselaar Terry, Broor Shobha, Barr Ian, Baumeister Elsa, Chadha Mandeep, Chittaganpitch Malinee, Darmaa Badarch, Ellis Joanna, Fasce Rodrigo, Herring Belinda, Herve Kadjo, Hirve Siddhivinayak, Li Yan, Pisareva Maria, Moen Ann, Naguib Amel, Palekar Rakhee, Potdar Varsha, Siqueira Marilda, Treurnicht Florette, Tivane Almiro, Venter Marietjie, Wairagkar Niteen, Zambon Maria, Zhang Wenqing

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

External quality assessments (EQAs) for the molecular detection of respiratory syncytial virus (RSV) are necessary to ensure the provision of reliable and accurate results. One of the objectives of the pilot of the World Health Organization (WHO) Global RSV Surveillance, 2016-2017, was to evaluate and standardize RSV molecular tests used by participating countries. This paper describes the first WHO RSV EQA for the molecular detection of RSV.

METHODS

The WHO implemented the pilot of Global RSV Surveillance based on the WHO Global Influenza Surveillance and Response System (GISRS) from 2016 to 2018 in 14 countries. To ensure standardization of tests, 13 participating laboratories were required to complete a 12 panel RSV EQA prepared and distributed by the Centers for Disease Control and Prevention (CDC), USA. The 14th laboratory joined the pilot late and participated in a separate EQA. Laboratories evaluated a RSV rRT-PCR assay developed by CDC and compared where applicable, other Laboratory Developed Tests (LDTs) or commercial assays already in use at their laboratories.

RESULTS

Laboratories performed well using the CDC RSV rRT-PCR in comparison with LDTs and commercial assays. Using the CDC assay, 11 of 13 laboratories reported correct results. Two laboratories each reported one false-positive finding. Of the laboratories using LDTs or commercial assays, results as assessed by Ct values were 100% correct for 1/5 (20%). With corrective actions, all laboratories achieved satisfactory outputs.

CONCLUSIONS

These findings indicate that reliable results can be expected from this pilot. Continued participation in EQAs for the molecular detection of RSV is recommended.

Для цитирования: Jackson Sandra, Peret Teresa C T, Ziegler Thedi T, Thornburg Natalie J, Besselaar Terry, Broor Shobha, Barr Ian, Baumeister Elsa, Chadha Mandeep, Chittaganpitch Malinee, Darmaa Badarch, Ellis Joanna, Fasce Rodrigo, Herring Belinda, Herve Kadjo, Hirve Siddhivinayak, Li Yan, Pisareva Maria, Moen Ann, Naguib Amel, Palekar Rakhee, Potdar Varsha, Siqueira Marilda, Treurnicht Florette, Tivane Almiro, Venter Marietjie, Wairagkar Niteen, Zambon Maria, Zhang Wenqing. Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17.. Influenza and other respiratory viruses. 2020. DOI: 10.1111/irv.12771.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.